Homology Medicines
Stock Forecast, Prediction & Price Target
Homology Medicines Financial Estimates
Homology Medicines Revenue Estimates
Homology Medicines EBITDA Estimates
Homology Medicines Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $33.97M N/A | $3.20M -90.55% | $-6.65M -307.32% | Avg: $2M Low: $2M High: $2M avg. 130.07% | Avg: $2M Low: $2M High: $2M avg. 0% | Avg: $2M Low: $2M High: $2M avg. 0% | Avg: $57.71M Low: $57.71M High: $57.71M avg. 2785.76% |
Net Income
% change YoY
| $-95.76M N/A | $-5.00M 94.77% | $-53.74M -973.78% | Avg: $-14.74M Low: $-14.74M High: $-14.74M avg. 72.55% | Avg: $-20.62M Low: $-20.62M High: $-20.62M avg. -39.86% | Avg: $-27.45M Low: $-27.45M High: $-27.45M avg. -33.09% | Avg: $-27.58M Low: $-27.58M High: $-27.58M avg. -0.46% |
EBITDA
% change YoY
| $-86.40M N/A | $-130.68M -51.24% | $-47.75M 63.45% | Avg: $-2M Low: $-2M High: $-2M avg. 95.81% | Avg: $-2M Low: $-2M High: $-2M avg. 0% | Avg: $-2M Low: $-2M High: $-2M avg. 0% | Avg: $-57.71M Low: $-57.71M High: $-57.71M avg. -2785.76% |
EPS
% change YoY
| -$31.18 N/A | -$1.57 94.96% | -$7.41 -371.97% | Avg: -$4.59 Low: -$4.59 High: -$4.59 avg. 38.05% | Avg: -$6.42 Low: -$6.42 High: -$6.42 avg. -39.86% | Avg: -$8.55 Low: -$8.55 High: -$8.55 avg. -33.09% | Avg: -$8.59 Low: -$8.59 High: -$8.59 avg. -0.46% |
Operating Expenses
% change YoY
| $120.37M N/A | $133.88M 11.22% | $9.87M -92.62% | Avg: $22.68M Low: $22.68M High: $22.68M avg. 129.74% | Avg: $22.68M Low: $22.68M High: $22.68M avg. 0% | Avg: $22.68M Low: $22.68M High: $22.68M avg. 0% | Avg: $654.71M Low: $654.71M High: $654.71M avg. 2785.76% |
FAQ
What is Homology Medicines stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -0.21% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -14.74M, average is -14.74M and high is -14.74M.
What is Homology Medicines stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 728.95% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $2M, average is $2M and high is $2M.
What is Homology Medicines stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -8.84% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$4.59, average is -$4.59 and high is $-4.59.